Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000724602 | SCV000233142 | uncertain significance | not provided | 2015-03-11 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000724602 | SCV000589942 | likely benign | not provided | 2020-02-05 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000180663 | SCV000595707 | likely benign | not specified | 2016-06-08 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001087689 | SCV001009240 | benign | Intellectual disability, autosomal dominant 1 | 2024-10-28 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002362927 | SCV002662068 | likely benign | Inborn genetic diseases | 2018-05-22 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV003947541 | SCV004759589 | likely benign | MBD5-related disorder | 2024-01-25 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |